Distribution and genotype frequency of adiponectin (+45 T/G) and adiponectin receptor2 (+795 G/A) single nucleotide polymorphisms in Iranian population

Gene

Volumn 486, Issue 1-2, 2011, Pages 97-103

  Namvaran, Fatemeh ^a,b   Azarpira, Negar ^b   Geramizadeh, Bita ^b   Rahimi Moghaddam, Parvaneh ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ADIPOQ gene; ADIPOR2 gene; Iranian population; Single nucleotide polymorphisms

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 2;

ARTICLE; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPONECTIN; ALLELES; BASE SEQUENCE; DNA PRIMERS; FEMALE; GENE FREQUENCY; HUMANS; IRAN; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADIPONECTIN;

EID: 84860390453     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.07.009     Document Type: Article

References (38)

1. Attia J., Thakkinstian A., D'Este C. Meta-analyses of molecular association studies: methodological lessons for genetic epidemiology. J. Clin. Epidemiol. 2003, 56:297-303.
2. Brookes A.J. The essence of SNPs. Gene 1999, 234:177-186.
3. Cesari M., Narkiewicz K., DeToni R., Aldighieri E., Williams C.J., Rossi G.P. Heritability of plasma adiponectin levels and body mass index in twins. J. Clin. Endocrinol. Metab. 2007, 92:3082-3088.
4. Chang Y.C., Jiang J.Y. Interaction of ADIPOQ genetic polymorphism with blood pressure and plasma cholesterol level on the risk of coronary artery disease. Circ. J. 2009, 73:1934-1938.
5. Chen M.P., Tsai J.C., Chung F.M., Yang S.S., Hsing L.L., Shin S.J., Lee Y.J. Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arterioscler. Thromb. Vasc. Biol. 2005, 25:821-826.
6. dbSNP (Database of Single Nucleotide Polymorphisms) Bethesda (MD): National Center for Biotechnology Information, National Library of Medicine. (dbSNP Build ID: 133) Available from. http://www.ncbi.nlm.nih.gov/SNP/.
7. Fang W.L., Zhou B., Wang Y.Y., Zhang L. Analysis of adiponectin gene polymorphisms in Chinese population with systemic lupus erythematosus. J. Biomed. Biotechnol. 2010, 5. volume 2010 Article ID 401537.
8. Farjadian S., Moghadam F.A., Ghaderi A. HLA class gene polymorphism in Parsees and Zoroastrians of Iran. Int. J. Immunogenet. 2006, 33:185-191.
9. Fumeron F., Aubert R., Siddiq A., Betoulle D. Adiponectin gene polymorphisms and levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. Diabetes 2004, 53:1150-1157.
10. Hara K., Boutin P., Mori Y., Tobe K., Dina C., Yasuda K., Yamauchi T., Otabe S., Okada T., Eto K., Kadowaki H., Hagura R., Akanuma Y., Yazaki Y., Nagai R., Taniyama M., Matsubara K., Yoda M., Nakano Y., Tomita M., Kimura S., Ito C., Froguel P., Kadowaki T. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002, 51:536-540.
11. Hegener H.H., Lee I.M., Cook N.R., Ridker P.M., Zee R.Y. Association of adiponectin gene variations with risk of incident myocardial infarction and ischemic stroke: a nested case-control study. Clin. Chem. 2006, 52:2021-2027.
12. Heid I.M., Wagner S.A., Gohlke H., Iglseder B., Mueller J.C., Cip P., Ladurner G., Reiter R., Stadlmayr A., Mackevics V., Illig T., Kronenberg F., Paulweber B. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 2006, 55:375-384.
13. Hu E., Liang P., Spiegelman B.M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 1996, 271:10697-10703.
14. José L., González-Sánchez 1., María J., María T., Martínez-Larrad 1. Interaction of the -308G/A promoter polymorphism of the tumor necrosis factor-gene with single-nucleotide polymorphism 45 of the adiponectin gene: effect on serum adiponectin concentrations in a Spanish population. Clin. Chem. 2006, 52:97-103.
15. Kadowaki T., Yamachi T. Adiponectin and adiponectin receptors. Endocrinol. Rev. 2005, 26:439-451.
16. Kaklamani V.G., Sadim M., Hsi A., Offit K., Oddoux C., Ostrer H., Ahsan H., Pasche B., Mantzoros C. Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. Cancer Res. 2008, 68:3178-3184.
17. Kaklamani V.G., Wisinski K.B., Sadim M., Gulden C., Do A., Offit K., Baron J.A., Ahsan H., Mantzoros C., Pasche B. Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA 2008, 300:1523-1531.
18. Kang E.S., Park S.Y., Kim H.J., Ahn C.W., Nam M., Cha B.S., Lim S.K., Kim K.R., Lee H.C. The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes. Diabetes Care 2005, 28:1139-1144.
19. Koshiishi C., Park H.M., Uchiyama H., Tanaka Y. Regulation of expression of the mouse adiponectin gene by the C/EBP family via a novel enhancer region. Gene 2008, 424:141-146.
20. Li L.L., Kang X.L., Ran X.J., Wang Y., Wang C.H., Huang L., Ren J., Luo X., Mao X.M. Associations between 45T/G polymorphism of the adiponectin gene and plasma adiponectin levels with type 2 diabetes. Clin. Exp. Pharmacol. Physiol. 2007, 34:1287-1290.
21. Matsuda M., Shimomura I., Sata M., Arita Y., Nishida M., Maeda N., Kumada M., Okamoto Y., Nagaretani H., Nishizawa H., Kishida K., Komuro R., Ouchi N., Kihara S., Nagai R., Funahashi T., Matsuzawa Y. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J. Biol. Chem. 2002, 277:37487-37491.
22. Mackevics V., Heid I.M., Wagner S.A., Cip P., Doppelmayr H. The adiponectin gene is associated with adiponectin levels but not with characteristics of the insulin resistance syndrome in healthy Caucasians. Eur. J. Hum. Genet. 2006, 14:349-356.
23. Menzaghi C., Ercolino T., Di Paola R., Berg A.H., Warram J.H., Scherer P.E., Trischitta V., Doria A. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002, 51:2306-2312.
24. Mohammadzadeh G., Zarghami N. Association between single-nucleotide polymorphisms of the adiponectin gene, serum adiponectin levels and increased risk of type 2 diabetes mellitus in Iranian obese individuals. Scand. J. clin. Lab. Invest. 2009, 69:764-771.
25. Ouchi N., Kihara S., Funahashi T., Matsuzawa Y., Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr. Opin. Lipidol. 2003, 14:561-566.
26. Panidis D., Kourtis A., Kukuvitis A., Farmakiotis D., Xita N., Georgiou I., Tsatsoulis A. Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of 4-androstenedione. Hum. Reprod. 2004, 19:1728-1733.
27. Pérez-Martínez P., López-Miranda J., Cruz-Teno C., Delgado-Lista J., Jiménez-Gómez Y., Fernández J.M., Gómez M.J., Marín C., Pérez-Jiménez F., Ordovás J.M. Adiponectin gene variants are associated with insulin sensitivity in response to dietary fat consumption in Caucasian men. J. Nutr. 2008, 138:1609-1614.
28. Populaire C., Mori Y., Dina C., Vasseur F., Vaxillaire M., Kadowaki T., Froguel P. Does the -11377 promoter variant of APM1 gene contribute to the genetic risk for Type 2 diabetes mellitus in Japanese families?. Diabetologia 2003, 46:443-445.
29. Potapov V.A., Chistiakov D.A., Dubinina A., Shamkhalova M.S., Shestakova M.V., Nosikov V.V. Adiponectin and adiponectin receptor gene variants in relation to type 2 diabetes and insulin resistance-related phenotypes. Rev. Diabet. Stud. 2008, 5:28-37.
30. Rasmussen-Torvik L.J., Pankow J.S., Jacobs Jr, Steinberger J., Moran A., Sinaiko A.R. Influence of waist on adiponectin and insulin sensitivity in adolescence. Obesity 2009, 17:156-161.
31. Shand B.I., Scott R.S., Elder P.A., George P.M. Plasma adiponectin in overweight, non-diabetic individuals with or without insulin resistance. Diabetes Obes. Metab. 2003, 5:349-353.
32. Statnick M.A., Beavers L.S., Conner L.J., Corominola H., Johnson D., Hammond C.D., Rafaeloff-Phail R., Seng T., Suter T.M., Sluka J.P., Ravussin E., Gadski R.A., Caro J.F. Decreased expression of APM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int. J. Exp. Diabetes Res. 2000, 1:81-88.
33. Stefan N., Vozarova B., Funahashi T., Matsuzawa Y., Weyer C., Lindsay R.S., Youngren J.F., Havel P.J., Pratley R.E., Bogardus C., Tataranni P.A. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 2002, 51:1884-1888.
34. Sun H., Gong Z.C., Yin J.Y., Liu H.L., Liu Y.Z., Guo Z.W., Zhou H.H., Wu J., Liu Z.Q. The association of adiponectin allele 45T/G and -11377C/G polymorphisms with Type 2 diabetes and rosiglitazone response in Chinese patients. Br. J. Clin. Pharmacol. 2008, 65:917-926.
35. Szopa M., Malczewska-Malec M., Wilk B., Skupien J., Wolkow P., Malecki M.T., Sieradzki J. Variants of the adiponectin gene and type 2 diabetes in a Polish population. Acta. Diabetol. 2009, 46:317-322.
36. Ukkola O., Ravussin E., Jacobson P., Sjostrom L., Bouchard C. Mutations in the adiponectin gene in lean and obese subjects from the Swedish Obese Subjects cohort. Metabolism 2003, 52:881-884.
37. Vasseur F., Helbecque N., Diana C., Lobbens S., Delannoy V., Gaget S., Boutin P., Vaxillaire M., Leprêtre F., Dupont S., Hara K., Clément K., Bihain B., Kadowaki T., Froguel P. Single nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the ADIPOQ gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk of type 2 diabetes in French Caucasians. Hum. Mol. Genet. 2002, 11:2607-2614.
38. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., Tataranni P.A. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 2001, 86:1930-1935.